Referanser

  1. Legemiddelverket.no - Foretrukket legemiddel for migrenebehandling
  2. FK-tekst Imigran
  3. Linde, Melberg & Dahløf; Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack; Cephalalgia 2005,26:118
  4. Preparatomtale Imigran
  5. Sheftell, Dahlõf, Agosti et al. Two Replicate Randomized Double-Blind, Placebo Controlled Trials of the Time on Onset of Pain Relief in the Acute Treatment of Migraine with a Fast-Disintegrating /Rapid-Release Tablets. Clinical Therapeutics, Vol 27, No.4, 2005, 407-417
  6. Agosti et al. Spead of Onset and Efficacy of Sumatriptan Fast-Disintegrating /Rapid-Release Tablets: Results of a European Randonized Placebo Controlled Study. Headache Care, Vol. 1, No. 4, 2004, 273-276
  7. Legemiddelhåndboken - T6.2.1  Migrene
  8. Dahlõf. Determining Triptan Preference for the Individual Patient. Headache 2004; 44-723-725
  9. Cady R, Schreiber C. Sumatriptan: update and review. Expert Opin Pharmacother 2006; 7(11):1503-1514
  10. Tfelt-Hansen P. Acute pharmacotherapy of migraine, tension-type headache, and cluster headache. J Headache Pain 2007; 8:127-134
  11. Tfelt-Hansen P. Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. A comment (review) J Headache Pain 2007; 8: 273-276
^ Til toppen

Publikumsinformasjon om migrene

Hvis du er pasient eller pårørende finner du relevant informasjon om behandling av migrene her.